Print Page | Contact Us | Sign In | Register
Online Store: DCMS Store Products
Main Storefront
        

CME: House Bill 21 Implementation

Item Options
Price: $55.00
Quantity: *
 
Description

After purchasing this CME Certification, you will receive a PDF download in your email containing the article and the evaluation. If you do not receive it, please check your spam box or contact kristy@dcmsonline.org.

 

The article, “A Committee-Based Systematic Response to Changes in Controlled Substance Law: The Example of House Bill 21 and UF Health Jacksonville” authored by Alberto E Ardon, MD, MPH, Brittany Johnson, PharmD, Brian Yorkgitis, DO, Joseph Cammilleri, PharmD, BCACP, Christopher B. Scuderi, DO, FAAFP, Jeffrey G. House, DO, FACP, and L. Kendall Webb, MD, FACEP, has been approved for 1 AMA PRA Category 1 credit.TM 

Faculty/Credentials:
Alberto E Ardon, MD, MPH, Assistant Professor, Anesthesiology. Brittany Johnson, PharmD, Pain and Palliative Care Stewardship Pharmacist. Brian Yorkgitis, DO, Assistant Professor of Surgery. Joseph Cammilleri, PharmD, BCACP, Ambulatory Care Clinical Pharmacist. Christopher B. Scuderi, DO, FAAFP, Associate Chair of Clinical Operations North, Clinical Associate Professor, Family Medicine. Jeffrey G. House, DO, FACP, Professor of Medicine. L. Kendall Webb, MD, FACEP, Chief Medical Information Officer, Associate Professor of Emergency Medicine and Pediatric Emergency Medicine. All are with UF Health Jacksonville.   

Objectives:

  1. Understand the critical factors involved with House Bill 21 “Controlled Substances” and implications for compliance.
  2. Describe the clinical, educational, and logistical issues associated with “Controlled Substances” compliance and how to address those issues.
  3. Discuss the benefits of using a multidisciplinary committee-based approach to achieve successful implementation.

Date of Release: April 1, 2019

Date Credit Expires: April 1, 2021

CME Credit Eligibility:
A minimum passing grade of 70% must be achieved. Only one re-take opportunity will be granted. 

Faculty Disclosure:
Alberto E Ardon, MD, MPH, Brittany Johnson, PharmD, Brian Yorkgitis, DO, Joseph Cammilleri, PharmD, BCACP, Christopher B. Scuderi, DO, FAAFP, Jeffrey G. House, DO, FACP, and L. Kendall Webb, MD, FACEP report no significant relations to disclose, financial or otherwise with any commercial supporter or product manufacturer associated with this activity.

Disclosure of Conflicts of Interest:
St. Vincent’s Healthcare (SVHC) requires speakers, faculty, CME Committee and other individuals who are in a position to control the content of this educations activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly evaluated by SVHC for fair balance, scientific objectivity of studies mentioned in the presentation and educational materials used as basis for content, and appropriateness of patient care recommendations. 

Joint Sponsorship Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of St. Vincent’s Healthcare and the Duval County Medical Society. St. Vincent’s Healthcare designates this educational activity for a maximum of 1 AMA PRA Category 1 credit.TM Physicians should only claim credit commensurate with the extent of their participation in the activity.